News

either tissue valve or mechanical valve,” he told us. In the elderly, as well as those not suited to open-heart surgery, Transcatheter Aortic Valve Replacement (TAVR) might be the best choice. It’s a ...
New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...
Findings from the Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) registry demonstrate that ...
Edwards Lifesciences (NYSE: EW) received FDA approval for its Sapien 3 TAVR for severe aortic stenosis (AS) without symptoms.
Findings from the Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) registry demonstrate that ...
The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.
FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...
Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe ...
The Society of Thoracic Surgeons (STS) today announced the launch of its latest surgical risk calculator designed for patients undergoing ascending aorta and aortic root surgery, with or without ...
Edwards’ SAPIEN 3 platform becomes the first TAVR system approved by the FDA for asymptomatic severe aortic stenosis patients ...
Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...